Shionogi & Co. Ltd.Shionogi & Co. Ltd.Shionogi & Co. Ltd.

Shionogi & Co. Ltd.

No trades
See on Supercharts
Next report date
Report period
Q4 2023
EPS estimate
0.22USD
Revenue estimate
‪668.60 M‬USD
Market capitalization
‪13.21 B‬USD
‪1.36 B‬USD
‪3.15 B‬USD
Beta (1Y)
0.40

About SHIONOGI & CO

CEO
Isao Teshirogi
Headquarters
Osaka
Employees (FY)
‪5.68 K‬
Founded
1878
FIGI
BBG000JSQ2R5
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.